Skip to main content
Log in

Anticonvulsant drugs and malformations is there a drug specificity?

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The distribution of anticonvulsant drug therapy was studied in 318 malformed infants with known histories of maternal epilepsy. Data on the infants was collected from six birth defect monitoring programs in Europe and South America.

Use of specific types of anticonvulsants varies midely among reporting countries. Heterogeneity of drug-malformation distribution, was analyzed to determine whether use of specific drugs were linked to specific malformations. A significant association was seen between maternal use of valproic acid and spina bifida, and a weaker, non-significant one between carbamazepine and spina bifida. Facial clefts were associated with both diphenylhydantoin and phenobarbitone use and also with polytherapy. These differences indicate that the actual drug used is significant for the teratogenic process. The technique may be useful in analyses of other drug-related teratogenic questions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. BertolliniR., KällénB., MastroiacovoP., RobertE. (1987): Anticonvulsant drugs in monotherapy. Effect on the fetus. - Eur. J. Epidemiol. 3: 164–171.

    Google Scholar 

  2. RobertE., LöfkvistE., MauguièreF., RobertJ.M. (1986): Evaluation of drug therapy and teratogenic risk in a Rhone-Alpes district population of pregnant epileptic women. - Eur. Neurol. 25: 436–443.

    Google Scholar 

  3. BertolliniR., MastroiacovoP., SegniG. (1985): Maternal epilepsy and birth defects: a case-control study in the Italian multicentric registry of birth defects (IPIMC). - Eur. J. Epidemiol. 1: 67–72.

    Google Scholar 

  4. BossiL. (1983): Fetal effects of anticonvulsants. In: Antiepileptic Drug Therapy in Pediatrics, edited by MorselliP.L., PippengerC.E. and PenryJ.K. Raven Press, New York, pp. 37–64.

    Google Scholar 

  5. KällénB. (1986): A register study of maternal epilepsy and delivery outcome with special reference to use. - Acta Neurol. Scand. 73: 253–259.

    Google Scholar 

  6. LammerE.J., SeverL.E., OakleyG.P.Jr. (1987): Teratogen update: Valproic acid. - Teratology 36: 465–473.

    Google Scholar 

  7. Rodriguez-PinillaE., SalvadorJ., AlonsoF.G., Martínez FriasM.L. (1985): Antiepilépticos y malformaciones congénitas: Estudio en una población espanola (1976–1983). - Farmacoterapia 2: 148–153.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Källén, B., Robert, E., Mastroiacovo, P. et al. Anticonvulsant drugs and malformations is there a drug specificity?. Eur J Epidemiol 5, 31–36 (1989). https://doi.org/10.1007/BF00145041

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00145041

Key words

Navigation